Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 11 | $1,589,598 |
| Sells | 10 | $79,148 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 25 Jun 2024 18:24 | GOSS | Gossamer Bio Inc | ARANDA RICHARD | Chief Medical Officer | 24 Jun 2024 | Sale | 1,908 | 0.6605 | 1,260 | D |
| 24 Jun 2024 17:52 | GOSS | Gossamer Bio Inc | HASNAIN FAHEEM | President & CEO | 21 Jun 2024 | Purchase | 372,000 | 0.6728 | 250,282 | I |
| 20 Jun 2024 20:21 | GOSS | Gossamer Bio Inc | GIRAUDO BRYAN | COO/CFO | 18 Jun 2024 | Purchase | 100,000 | 0.5911 | 59,110 | I |
| 20 Jun 2024 20:20 | GOSS | Gossamer Bio Inc | SMITH ROBERT PAUL JR | Chief Commercial Officer | 17 Jun 2024 | Purchase | 25,000 | 0.602 | 15,050 | I |
| 28 Mar 2024 18:16 | GOSS | Gossamer Bio Inc | CHRISTIAN WAAGE | EVP, Tech Ops and Admin | 27 Mar 2024 | Sale | 6,430 | 1.1555 | 7,430 | D |
| 28 Mar 2024 18:05 | GOSS | Gossamer Bio Inc | GIRAUDO BRYAN | COO/CFO | 27 Mar 2024 | Sale | 6,430 | 1.1556 | 7,431 | D |
| 28 Mar 2024 18:01 | GOSS | Gossamer Bio Inc | HASNAIN FAHEEM | President & CEO | 27 Mar 2024 | Sale | 23,172 | 1.1554 | 26,773 | D |
| 19 Mar 2024 18:50 | GOSS | Gossamer Bio Inc | ARANDA RICHARD | Chief Medical Officer | 18 Mar 2024 | Sale | 4,018 | 1.3295 | 5,342 | D |
| 19 Mar 2024 18:50 | GOSS | Gossamer Bio Inc | PETERSON CARYN | EVP, Regulatory Affairs | 18 Mar 2024 | Sale | 4,018 | 1.3297 | 5,343 | D |
| 17 Nov 2023 16:01 | GOSS | Gossamer Bio Inc | MILLIGAN SANDRA | Director | 15 Nov 2023 | Purchase | 32,000 | 0.7879 | 25,213 | I |
| 14 Nov 2023 18:24 | GOSS | Gossamer Bio Inc | GIRAUDO BRYAN | COO/CFO | 13 Nov 2023 | Purchase | 200,000 | 0.5644 | 112,880 | I |
| 26 Jun 2023 16:01 | GOSS | Gossamer Bio Inc | ARANDA RICHARD | Chief Medical Officer | 22 Jun 2023 | Sale | 1,814 | 1.29 | 2,340 | D |
| 05 Apr 2023 16:26 | GOSS | Gossamer Bio Inc | GIRAUDO BRYAN | COO/CFO | 04 Apr 2023 | Purchase | 55,000 | 1.0199 | 56,094 | I |
| 22 Mar 2023 17:19 | GOSS | Gossamer Bio Inc | CHRISTIAN WAAGE | EVP, Tech Ops and Admin | 20 Mar 2023 | Purchase | 18,500 | 1.197 | 22,144 | I |
| 22 Mar 2023 17:17 | GOSS | Gossamer Bio Inc | GIRAUDO BRYAN | COO/CFO | 20 Mar 2023 | Purchase | 50,000 | 0.9687 | 48,435 | I |
| 22 Mar 2023 17:14 | GOSS | Gossamer Bio Inc | HASNAIN FAHEEM | President & CEO | 22 Mar 2023 | Purchase | 440,500 | 1.1432 | 503,580 | I |
| 22 Mar 2023 17:14 | GOSS | Gossamer Bio Inc | HASNAIN FAHEEM | President & CEO | 21 Mar 2023 | Purchase | 269,389 | 1.1965 | 322,324 | I |
| 22 Mar 2023 17:14 | GOSS | Gossamer Bio Inc | HASNAIN FAHEEM | President & CEO | 20 Mar 2023 | Purchase | 168,683 | 1.0344 | 174,486 | I |
| 20 Mar 2023 09:22 | GOSS | Gossamer Bio Inc | CARTER LAURA | Chief Scientific Officer | 16 Mar 2023 | Sale | 6,029 | 1.098 | 6,620 | D |
| 20 Mar 2023 09:21 | GOSS | Gossamer Bio Inc | ARANDA RICHARD | Chief Medical Officer | 16 Mar 2023 | Sale | 7,563 | 1.098 | 8,304 | D |
| 20 Mar 2023 09:19 | GOSS | Gossamer Bio Inc | PETERSON CARYN | EVP, Regulatory Affairs | 16 Mar 2023 | Sale | 7,564 | 1.098 | 8,305 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)